Blau Farmacêutica S.A.   Report issue

For profit Phase 1 Phase 3
Founded: Branco Cotia Brazil (1987)
Status: No NME R&D (1987)

Organization Overview

First Clinical Trial
2012
NCT03572647
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Blau Farmaceutica S.A. | Blau Farmacêutica S.A.

Active Ingredients

Drugs in Phase 3 Trials (2)

epoetin (Epogen) (2 trials)

Filgrastim (neupogen) (1 trial)

Drugs in Phase 1 Trials (1)

heparin (liquaemin) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Renal Insufficiency (Phase 1)

Renal Insufficiency, Chronic (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 3